Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kymera Therapeutics, Inc. (KYMR)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 62,339,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Kymera Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Co.'s proprietary targeted protein degradation platform, which Co. refers to as Pegasus™, allows Co. to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. Co. has utilized its Pegasus™ platform to design protein degraders focused in the areas of immunology-inflammation and oncology, and Co. continues to apply its platform's capabilities to additional therapeutic areas.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 414,105 414,105 1,550,163
Total Buy Value $0 $5,301,325 $5,301,325 $29,893,245
Total People Bought 0 1 1 1
Total Buy Transactions 0 2 2 10
Total Shares Sold 893,072 906,367 906,367 2,944,621
Total Sell Value $37,113,975 $37,488,861 $37,488,861 $99,885,268
Total People Sold 5 6 6 7
Total Sell Transactions 17 19 19 49
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 204
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baker Bros Advisors Llc   –       •      –    2024-03-28 3 IO $0.00 $0 I/I 0 5,995,928     -
   Booth Bruce   –       •      –    2024-03-15 4 AS $39.31 $2,903,336 I/I (71,764) 806,697     -
   Booth Bruce   –       •      –    2024-03-14 4 AS $39.73 $2,229,927 I/I (55,779) 819,151     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-03-13 4 AS $42.19 $1,020,422 I/I (24,165) 828,830     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-03-13 4 AS $42.19 $4,859,993 D/D (115,090) 4,676,075     -
   Booth Bruce   –       •      –    2024-03-13 4 AS $42.19 $5,880,415 I/I (139,255) 828,830     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-03-12 4 AS $41.94 $1,186,741 I/I (28,271) 852,995     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-03-12 4 AS $41.94 $5,652,072 D/D (134,647) 4,791,165     -
   Booth Bruce   –       •      –    2024-03-12 4 AS $41.94 $6,838,813 I/I (162,918) 852,995     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-03-11 4 AS $42.77 $380,562 I/I (8,882) 881,266     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-03-11 4 AS $42.77 $1,812,586 D/D (42,302) 4,925,812     -
   Booth Bruce   –       •      –    2024-03-11 4 AS $42.77 $2,193,148 I/I (51,184) 881,266     -
   Gollob Jared Chief Medical Officer   •       –      –    2024-03-04 4 S $41.41 $139,967 D/D (3,344) 95,740     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2024-03-04 4 S $41.41 $164,664 D/D (3,934) 142,351     -
   Gollob Jared Chief Medical Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 24,375 99,084     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 31,250 146,285     -
   Chiniara Ellen Chief Legal Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 21,755 55,960     -
   Chadwick Jeremy G Chief Operating Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 13,425 46,758     -
   Gollob Jared Chief Medical Officer   •       –      –    2024-02-27 4 AS $45.00 $18,000 D/D (400) 74,709     -
   Gollob Jared Chief Medical Officer   •       –      –    2024-02-27 4 OE $2.08 $832 D/D 400 75,109     -
   Albers Jeffrey W.   –       •      –    2024-02-21 4 AS $39.05 $171,227 D/D (4,385) 0     -
   Albers Jeffrey W.   –       •      –    2024-02-21 4 OE $10.34 $45,341 D/D 4,385 4,385     -
   Albers Jeffrey W.   –       •      –    2024-02-20 4 AS $39.07 $24,031 D/D (615) 0     -
   Albers Jeffrey W.   –       •      –    2024-02-20 4 OE $10.34 $6,359 D/D 615 615     -
   Gollob Jared Chief Medical Officer   •       –      –    2024-02-09 4 AS $35.39 $1,638,071 D/D (46,137) 74,709     -
  204 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us